Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$851M |
| 2 |
Apple
AAPL
|
+$663M |
| 3 |
UnitedHealth
UNH
|
+$206M |
| 4 |
Cisco
CSCO
|
+$192M |
| 5 |
Johnson & Johnson
JNJ
|
+$183M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$559M |
| 2 |
Broadcom
AVGO
|
+$224M |
| 3 |
United Rentals
URI
|
+$189M |
| 4 |
CRH
CRH
|
+$177M |
| 5 |
Pfizer
PFE
|
+$174M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.61% |
| 2 | Financials | 17.11% |
| 3 | Industrials | 13.24% |
| 4 | Consumer Discretionary | 11.1% |
| 5 | Healthcare | 10.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3101
Envela
ELA
$563M
| $364K | ﹤0.01% |
78,711
-8,684
| -10% | -$38.6K |
|
|
RDIB
3102
Reading International Class B
RDIB
$192M
| $362K | ﹤0.01% |
24,836
-591
| -2% | -$8.55K |
|
3103
Apyx Medical
APYX
$173M
| $362K | ﹤0.01% |
265,857
-83,336
| -24% | -$177K |
|
3104
Telus
TU
$16.8B
| $361K | ﹤0.01% |
22,579
-514
| -2% | -$8.99K |
|
3105
CKX Lands
CKX
$22.2M
| $360K | ﹤0.01% |
27,298
-2,578
| -9% | -$34.2K |
|
|
GORV
3106
DELISTED
Lazydays
GORV
| $356K | ﹤0.01% |
2,943
| – | – |
|
|
AZUL
3107
DELISTED
Azul
AZUL
| $351K | ﹤0.01% |
45,169
-2,459
| -5% | -$19.5K |
|
|
ELEV
3108
DELISTED
Elevation Oncology
ELEV
| $351K | ﹤0.01% |
+68,348
| New | +$221K |
|
3109
ReposiTrak
TRAK
$157M
| $350K | ﹤0.01% |
22,104
-4,581
| -17% | -$60.1K |
|
3110
Koss Corp
KOSS
$34.8M
| $350K | ﹤0.01% |
136,145
-360
| -0.3% | -$1K |
|
|
WMPN
3111
DELISTED
William Penn Bancorporation Common Stock
WMPN
| $348K | ﹤0.01% |
28,185
| – | – |
|
3112
Relmada Therapeutics
RLMD
$562M
| $343K | ﹤0.01% |
73,820
| – | – |
|
3113
Biote Corp
BTMD
$67.3M
| $343K | ﹤0.01% |
59,113
-17,479
| -23% | -$87.6K |
|
3114
Lake Shore Bancorp
LSBK
$135M
| $343K | ﹤0.01% |
29,076
+2,138
| +8% | +$25K |
|
3115
Purple Innovation
PRPL
$31.6M
| $338K | ﹤0.01% |
7,765
-6,111
| -44% | -$204K |
|
3116
Kentucky First Federal Bancorp
KFFB
$44.5M
| $338K | ﹤0.01% |
88,420
-484
| -0.5% | -$1.91K |
|
3117
ImmuCell
ICCC
$100M
| $336K | ﹤0.01% |
63,401
+5,950
| +10% | +$30.6K |
|
3118
Cosan
CSAN
$3.12B
| $336K | ﹤0.01% |
25,938
+9,112
| +54% | +$131K |
|
|
GTHX
3119
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $335K | ﹤0.01% |
77,531
+865
| +1% | +$3.01K |
|
|
NOTV
3120
DELISTED
Inotiv
NOTV
| $332K | ﹤0.01% |
30,329
| – | – |
|
3121
Traeger
COOK
$171M
| $326K | ﹤0.01% |
2,579
+354
| +16% | +$40.3K |
|
3122
CPI Aerostructures
CVU
$64.1M
| $326K | ﹤0.01% |
139,338
| – | – |
|
3123
CPI Card Group
PMTS
$236M
| $325K | ﹤0.01% |
18,196
-504
| -3% | -$9.18K |
|
3124
Flotek Industries
FTK
$847M
| $325K | ﹤0.01% |
86,814
| – | – |
|
|
LNKB
3125
DELISTED
LINKBANCORP
LNKB
| $323K | ﹤0.01% |
46,544
+27,913
| +150% | +$201K |
|
Similar funds
Dimensional Fund Advisors's Q1 2024 Portfolio in Review
As of Q1 2024, Dimensional Fund Advisors held 3,470 positions worth $369B, up 7.9% from $342B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Trading was light in Q1 2024: portfolio turnover was 4.1%. Dimensional Fund Advisors opened 58 new positions and exited 83, leaving the 3,470-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Industrials.
- Dimensional Fund Advisors's largest Q1 2024 buy was Arcadium Lithium plc: 8,775,487 shares worth $37.8M.
- Dimensional Fund Advisors added most to NVIDIA in Q1 2024, an estimated $851M increase.
- Dimensional Fund Advisors's biggest Q1 2024 reduction was Meta Platforms (Facebook), cutting an estimated $559M.
- Dimensional Fund Advisors fully exited Textainer Group Holdings limited in Q1 2024, selling an estimated $161M.
- Dimensional Fund Advisors's ten largest holdings make up 13% of its $369B portfolio in Q1 2024.
- Dimensional Fund Advisors opened 58 new positions and closed 83 in Q1 2024.
- Dimensional Fund Advisors's portfolio value rose 7.9% quarter-over-quarter to $369B.
Based on Dimensional Fund Advisors's 13F filing for Q1 2024, filed 10 May 2024.